Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGAV | P06756 | 20/20 | 0.69 |
| ▸ | ITGB3 | P05106 | 18/20 | 0.69 |
| ▸ | ITGA2B | P08514 | 10/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7969280 | 0.95 | ITGAV (0.61) | ITGAVITGB3ITGA2B | |
| SCHEMBL7969143 | 0.90 | ITGAV (0.56) | ITGAVITGB3ITGA2B | |
| SCHEMBL7985851 | 0.88 | ITGB3 (0.53) | ITGAVITGB3ITGA2B | |
| SCHEMBL7969222 | 0.86 | ITGAV (0.59) | ITGAVITGB3ITGA2B | |
| SCHEMBL7980623 | 0.86 | ITGB3 (0.69) | ITGAVITGB3ITGA2B | |
| SCHEMBL7969099 | 0.85 | ITGAV (0.50) | ITGAVITGB3ITGA2B | |
| SCHEMBL7979100 | 0.85 | ITGAV (0.68) | ITGAVITGB3ITGA2B | |
| SCHEMBL7985901 | 0.82 | ITGAV (0.47) | ITGAVITGB3ITGA2B | |
| SCHEMBL7982824 | 0.82 | ITGB3 (1.00) | ITGAVITGB3ITGA2B | |
| Trifluoroacetic Acid SCHEMBL7979079 | 0.82 | ITGAV (0.64) | ITGAVITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6214834-B1 | ANGIOGENESIS INHIBITORS; ANTIINFLAMMATORY AGENTS; ANTICANCER AGENTS | DUPONT PHARMACEUTICALS COMPANY | 2001-04-10 | — | — | US | claimed |
| US-6214834-B1 | ANGIOGENESIS INHIBITORS; ANTIINFLAMMATORY AGENTS; ANTICANCER AGENTS | DUPONT PHARMACEUTICALS COMPANY | 2001-04-10 | — | — | US | disclosed |
| US-5760028-A | TREATING CANCER METASTASIS, DIABETIC RETINOPATHY, NEOVASCULAR GLAUCOMA, THROMBOSIS, RESTENOSIS, OSTEOPOROSIS, MACULAR DEGENERATION | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1998-06-02 | — | — | US | disclosed |